Cargando…

Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor

The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Beljantseva, Jelena, Kudrin, Pavel, Jimmy, Steffi, Ehn, Marcel, Pohl, Radek, Varik, Vallo, Tozawa, Yuzuru, Shingler, Victoria, Tenson, Tanel, Rejman, Dominik, Hauryliuk, Vasili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291098/
https://www.ncbi.nlm.nih.gov/pubmed/28157202
http://dx.doi.org/10.1038/srep41839
_version_ 1782504728104534016
author Beljantseva, Jelena
Kudrin, Pavel
Jimmy, Steffi
Ehn, Marcel
Pohl, Radek
Varik, Vallo
Tozawa, Yuzuru
Shingler, Victoria
Tenson, Tanel
Rejman, Dominik
Hauryliuk, Vasili
author_facet Beljantseva, Jelena
Kudrin, Pavel
Jimmy, Steffi
Ehn, Marcel
Pohl, Radek
Varik, Vallo
Tozawa, Yuzuru
Shingler, Victoria
Tenson, Tanel
Rejman, Dominik
Hauryliuk, Vasili
author_sort Beljantseva, Jelena
collection PubMed
description The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC(50) in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work.
format Online
Article
Text
id pubmed-5291098
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52910982017-02-07 Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor Beljantseva, Jelena Kudrin, Pavel Jimmy, Steffi Ehn, Marcel Pohl, Radek Varik, Vallo Tozawa, Yuzuru Shingler, Victoria Tenson, Tanel Rejman, Dominik Hauryliuk, Vasili Sci Rep Article The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC(50) in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work. Nature Publishing Group 2017-02-03 /pmc/articles/PMC5291098/ /pubmed/28157202 http://dx.doi.org/10.1038/srep41839 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Beljantseva, Jelena
Kudrin, Pavel
Jimmy, Steffi
Ehn, Marcel
Pohl, Radek
Varik, Vallo
Tozawa, Yuzuru
Shingler, Victoria
Tenson, Tanel
Rejman, Dominik
Hauryliuk, Vasili
Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
title Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
title_full Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
title_fullStr Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
title_full_unstemmed Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
title_short Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
title_sort molecular mutagenesis of ppgpp: turning a rela activator into an inhibitor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291098/
https://www.ncbi.nlm.nih.gov/pubmed/28157202
http://dx.doi.org/10.1038/srep41839
work_keys_str_mv AT beljantsevajelena molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT kudrinpavel molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT jimmysteffi molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT ehnmarcel molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT pohlradek molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT varikvallo molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT tozawayuzuru molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT shinglervictoria molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT tensontanel molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT rejmandominik molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor
AT hauryliukvasili molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor